{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:34:59Z","timestamp":1793370899352,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ther Innov Regul Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s43441-026-01019-6","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:54:52Z","timestamp":1783792492000},"page":"1710-1719","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece"],"prefix":"10.1007","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2428-9939","authenticated-orcid":false,"given":"Iva","family":"Nenkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2992-8423","authenticated-orcid":false,"given":"Petya","family":"Pavlikyanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-276X","authenticated-orcid":false,"given":"Adina","family":"Turcu-Stiolica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-2976","authenticated-orcid":false,"given":"Mihaela-Simona","family":"Naidin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8680-062X","authenticated-orcid":false,"given":"Athanasios","family":"Margetis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4856-3665","authenticated-orcid":false,"given":"Stanislava","family":"Yordanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1949-1212","authenticated-orcid":false,"given":"Assena","family":"Serbezova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4379-5283","authenticated-orcid":false,"given":"Maria","family":"Kamusheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"1019_CR1","unstructured":"European Commission. Rare diseases and European Reference Networks. Rare diseases. https:\/\/health.ec.europa.eu\/rare-diseases-and-european-reference-networks\/rare-diseases_en#x. Accessed 16 Mar 2025."},{"key":"1019_CR2","unstructured":"Regulation (EC). Mar No 141\/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products. https:\/\/eur-lex.europa.eu\/eli\/reg\/2000\/141\/oj. Accessed 16 2025."},{"key":"1019_CR3","doi-asserted-by":"crossref","unstructured":"The Lancet Global Health. The landscape for rare diseases in 2024. Lancet Glob Health. 2024;12(3):e34. https:\/\/www.thelancet.com\/pdfs\/journals\/langlo\/PIIS2214-109X(24)00056-1.pdf. Accessed 21 Mar 2025.","DOI":"10.1016\/S2214-109X(24)00056-1"},{"key":"1019_CR4","unstructured":"Ipsos, Mar. ASAP for Children. : European Rare Diseases Observatory - full report. https:\/\/www.ipsos.com\/sites\/default\/files\/ct\/news\/documents\/2024-11\/ipsos-asap-for-children-european-rare-diseases-observatory-full-report.pdf. Accessed 21 2025."},{"issue":"2","key":"1019_CR5","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.5504\/BBEQ.2011.0043","volume":"25","author":"A Stoimenova","year":"2011","unstructured":"Stoimenova A, Manova M, Savova A, et al. Reimbursed orphan medicines in Bulgaria and the share of biotechnology-derived products. Biotechnol Biotechnol Equip. 2011;25(2):2418\u201323. https:\/\/doi.org\/10.5504\/BBEQ.2011.0043","journal-title":"Biotechnol Biotechnol Equip"},{"key":"1019_CR6","doi-asserted-by":"publisher","first-page":"5572290","DOI":"10.1155\/ijpe\/5572290","volume":"2025","author":"P Tsitsani","year":"2025","unstructured":"Tsitsani P, Papamitsou T, Malliarou M, et al. Exploring current health policies on rare diseases in Greece: a narrative review. Int J Pediatr. 2025;2025:5572290. https:\/\/doi.org\/10.1155\/ijpe\/5572290","journal-title":"Int J Pediatr"},{"key":"1019_CR7","doi-asserted-by":"publisher","first-page":"852880","DOI":"10.3389\/fpubh.2022.852880","volume":"10","author":"E Severin","year":"2022","unstructured":"Severin E, Dan D. Lack of information on the effects of COVID-19 on rare pathologies has further hampered access to healthcare services. Front Public Health. 2022;10:852880. https:\/\/doi.org\/10.3389\/fpubh.2022.852880","journal-title":"Front Public Health"},{"key":"1019_CR8","unstructured":"European Commission. Orphan medicinal products. https:\/\/health.ec.europa.eu\/medicinal-products\/orphan-medicinal-products_en. Accessed 16 Mar 2025."},{"key":"1019_CR9","unstructured":"Council Recommendation of 8 June. 2009 on an action in the field of rare diseases (2009\/C 151\/02). https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:C:2009:151:0007:0010:EN:PDF. Accessed 20 Jan 2026."},{"key":"1019_CR10","unstructured":"Directive 2011\/24\/EU of the European Parliament and of the Council of 9. March 2011 on the application of patients\u2019 rights in cross-border healthcare. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32011L0024. Accessed 20 Jan 2026."},{"key":"1019_CR11","unstructured":"EURORDIS. Revisions for the better: how Europe should boost the development of rare disease medicines. 2023. https:\/\/www.eurordis.org\/revisions-for-the-better\/. Accessed 21 Mar 2025."},{"issue":"4","key":"1019_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3897\/pharmacia.68.e73240","volume":"68","author":"M Kamusheva","year":"2021","unstructured":"Kamusheva M, Milushewa P. Rare disease patients\u2019 needs: an up-to-date analysis and future directions. Pharmacia. 2021;68(4):763\u201370. https:\/\/doi.org\/10.3897\/pharmacia.68.e73240","journal-title":"Pharmacia"},{"key":"1019_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13023-018-0927-y","volume":"13","author":"M Szegedi","year":"2018","unstructured":"Szegedi M, Zelei T, Arickx F, et al. The European challenges of funding orphan medicinal products. Orphanet J Rare Dis. 2018;13:184. https:\/\/doi.org\/10.1186\/s13023-018-0927-y","journal-title":"Orphanet J Rare Dis"},{"key":"1019_CR14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jmahp13020024","volume":"13","author":"T Kluszczynski","year":"2025","unstructured":"Kluszczynski T, Nemeth B, W\u0142adysiuk M, et al. Optimizing patient access to orphan medicinal products: lessons from Central and Eastern Europe. J Mark Access Health Policy. 2025;13:24. https:\/\/doi.org\/10.3390\/jmahp13020024","journal-title":"J Mark Access Health Policy"},{"key":"1019_CR15","unstructured":"European Commission. Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions: Pharmaceutical Strategy for Europe. 2020. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:52020DC0761. Accessed 21 Mar 2025."},{"key":"1019_CR16","unstructured":"European Commission. Reform of the EU pharmaceutical legislation. 2023 Apr 26. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX:52023PC0193. Accessed 21 Mar 2025."},{"key":"1019_CR17","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1016\/j.rare.2024.100018","volume":"2","author":"P Pakter","year":"2024","unstructured":"Pakter P. Rare disease care in Europe \u2013 Gaping unmet needs. Rare. 2024;2:100018. https:\/\/doi.org\/10.1016\/j.rare.2024.100018.","journal-title":"Rare"},{"issue":"5","key":"1019_CR18","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.5504\/BBEQ.2013.0066","volume":"27","author":"M Kamusheva","year":"2013","unstructured":"Kamusheva M, Stoimenova A, Doneva M, et al. A cross-country comparison of reimbursed orphan medicines in Bulgaria, Greece and Romania. Biotechnol Biotechnol Equip. 2013;27(5):4186\u201392. https:\/\/doi.org\/10.5504\/BBEQ.2013.0066.","journal-title":"Biotechnol Biotechnol Equip"},{"key":"1019_CR19","doi-asserted-by":"publisher","first-page":"275508342412558","DOI":"10.1177\/27550834241255838","volume":"8","author":"I Maslyankov","year":"2024","unstructured":"Maslyankov I. Unmet healthcare needs in Southeastern Europe: a systematic review. J Med Access. 2024;8:27550834241255838. https:\/\/doi.org\/10.1177\/27550834241255838","journal-title":"J Med Access"},{"issue":"1","key":"1019_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13023-017-0618-0","volume":"12","author":"S Dharssi","year":"2017","unstructured":"Dharssi S, Wong-Rieger D, Harold M, Terry S. Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis. 2017;12(1):63. https:\/\/doi.org\/10.1186\/s13023-017-0618-0.","journal-title":"Orphanet J Rare Dis"},{"key":"1019_CR21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s12687-021-00525-4","volume":"12","author":"V Hedley","year":"2021","unstructured":"Hedley V, Bottarelli V, Weinman A, et al. Shaping national plans and strategies for rare diseases in Europe: past, present, and future. J Community Genet. 2021;12:207\u201316. https:\/\/doi.org\/10.1007\/s12687-021-00525-4","journal-title":"J Community Genet"},{"issue":"Suppl 1","key":"1019_CR22","doi-asserted-by":"publisher","first-page":"P13","DOI":"10.1186\/1750-1172-9-S1-P13","volume":"9","author":"C Rodwell","year":"2014","unstructured":"Rodwell C, Aym\u00e9 S. Evolution of national and European policies in the field of rare diseases and their impact over the past five years. Orphanet J Rare Dis. 2014;9(Suppl 1):P13. https:\/\/doi.org\/10.1186\/1750-1172-9-S1-P13","journal-title":"Orphanet J Rare Dis"},{"key":"1019_CR23","unstructured":"Health Act. 2005. https:\/\/www.mh.government.bg\/upload\/12273\/Zakon%20za%20zdraveto%2014-10-2024.pdf. Accessed 21 Mar 2025. (in Bulgarian)."},{"key":"1019_CR24","unstructured":"Ordinance 22. 2005, repealed in 2009. https:\/\/www.mh.government.bg\/upload\/4808\/naredba22-ot-18-07-2005g.rtf. Accessed 21 Mar 2025. (in Bulgarian)."},{"key":"1019_CR25","unstructured":"Medicinal Products in Human Medicine Act. 2007. https:\/\/www.mh.government.bg\/upload\/68\/zakon-za-lekarstvenite-produkti-v-humannata-meditsina_21-12-2012.pdf. Accessed 21 Mar 2025. (in Bulgarian)."},{"key":"1019_CR26","unstructured":"National Programme for Rare Diseases. (2009\u20132013). https:\/\/www.raredis.org\/pub\/events\/NPRD.pdf Accessed 21 Mar 2025."},{"key":"1019_CR27","unstructured":"Romanian National Plan for Rare Diseases 2010\u20132014. Draft. January 2010. https:\/\/www.apwromania.ro\/old\/download\/rom_plan_rd.pdf. Accessed 21 Mar 2025."},{"key":"1019_CR28","unstructured":"National Health Strategy 2014\u20132020, Romania. https:\/\/platform.who.int\/docs\/default-source\/mca-documents\/policy-documents\/plan-strategy\/ROU-CC-10-01-PLAN-STRATEGY-eng-National-Health-Strategy-2014-2020.pdf. Accessed 21 Mar 2025."},{"key":"1019_CR29","unstructured":"Order No. 1215 of 23, the establishment of the National Council for Rare Diseases. October 2013 on the approval of. Ministry of Health; published in the Official Gazette No. 658 of 25 October 2013. https:\/\/legislatie.just.ro\/Public\/DetaliiDocument\/152060. Accessed 16 Jun 2025. (in Romanian)."},{"key":"1019_CR30","unstructured":"Order No. 1358 of 13 November 2014 on the establishment of the National Medical Genetics Network. Ministry of Health; published in Official Gazette, Part I, No. 848 of 20. November 2014. https:\/\/legislatie.just.ro\/Public\/DetaliiDocument\/163135. Accessed 16 Jun 2025. (in Romanian)."},{"key":"1019_CR31","unstructured":"Order No. 540 of 28 April 2016 on the organisation, operation and certification methodology of centres of expertise for rare diseases. Ministry of Health; published in Official Gazette, Part I, No. 331 of 29 Apr 2016. https:\/\/legislatie.just.ro\/Public\/DetaliiDocument\/178054. Accessed 16 Jun 2025 (in Romanian)."},{"key":"1019_CR32","unstructured":"Law 4213\/2013. Government Gazette of Greece. 2013. Available from: https:\/\/www.kodiko.gr\/nomothesia\/document\/982\/nomos-4213-2013. Accessed 06 May 2026."},{"key":"1019_CR33","unstructured":"Law 4461\/2017. Government Gazette of Greece. 2017. Available from: https:\/\/www.kodiko.gr\/nomothesia\/document\/256244\/nomos-4461-2017. Accessed 06 May 2026."},{"key":"1019_CR34","unstructured":"Ordinance \u2116 16 of 30 July. 2014 on the terms and conditions for registration of rare diseases and on the expert centers and reference networks for rare diseases. https:\/\/ncpha.government.bg\/uploads\/za%20nas\/struktura\/MH_20140730_No16-RareDiseases_Registration.pdf. Accessed 16 Jun 2025. (in Bulgarian)."},{"key":"1019_CR35","unstructured":"Register of expert centres for rare diseases in Bulgaria. https:\/\/ncpha.government.bg\/index\/131-registur-na-ekspertnite-centrove-po-redki-zaboliavania.html. Accessed 10 Mar 2025. (in Bulgarian)."},{"key":"1019_CR36","unstructured":"Romanian Ministry of Health. Activity Report for 2024 (Raportul de activitate pentru anul 2024). Bucharest: Ministry of Health. 2025. Available from: https:\/\/ms.ro\/media\/documents\/Raport_de_activitate_pentru_anul_2024.pdf. Accessed 6 May 2026."},{"key":"1019_CR37","unstructured":"European Commission. ERN Service Directory. European Reference Networks (ERNs). https:\/\/webgate.ec.europa.eu\/ernsd\/screen\/public?npage=ern_portal.html#!\/. Accessed 11 Jun 2025."},{"key":"1019_CR38","unstructured":"Rare diseases profiles included in the official Bulgarian rare disease list. https:\/\/www.amgenlab.com\/uploads\/MyDocuments\/12_spisak-na-redkite-bolesti-v-balgariya.pdf. Accessed 07 Mar 2025. (in Bulgarian)."},{"key":"1019_CR39","unstructured":"Government Gazette of the Hellenic Republic. Issue of the Greek Catalogue of Rare Diseases (ORPHAcodes). Ministerial Decision No. \u03932\u03b4\/67445. Government Gazette B\u2019 248, 17 January 2024. (in Greek). https:\/\/www.elinyae.gr\/sites\/default\/files\/2024-01\/248%CE%B2_2024.pdf. Accessed 25 Jan 2026."},{"key":"1019_CR40","unstructured":"Orphanet. Rare disease registries in Europe. Orphanet Report Series; 2024. https:\/\/www.orpha.net\/pdfs\/orphacom\/cahiers\/docs\/GB\/Rare_Disease_Registries.pdf. Accessed 07 Mar 2025."},{"key":"1019_CR41","unstructured":"Action Plan for the implementation of the National Strategy for Child and Adolescent Health and Pediatric. Care 2030 for the period 2023\u20132025. https:\/\/www.strategy.bg\/FileHandler.ashx?fileId=34136. Accessed 07 Mar 2025. (in Bulgarian)."},{"key":"1019_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/rjpm1010020","volume":"1","author":"V Dima","year":"2022","unstructured":"Dima V. Newborn screening in Romania\u2013present and future. Rom J Prev Med. 2022;1:20\u20136. https:\/\/doi.org\/10.3390\/rjpm1010020.","journal-title":"Rom J Prev Med"},{"key":"1019_CR43","doi-asserted-by":"publisher","first-page":"648939","DOI":"10.3389\/fped.2021.648939","volume":"9","author":"V Koracin","year":"2021","unstructured":"Koracin V, Mlinaric M, Baric I, et al. Current status of newborn screening in Southeastern Europe. Front Pediatr. 2021;9:648939. https:\/\/doi.org\/10.3389\/fped.2021.648939.","journal-title":"Front Pediatr"},{"key":"1019_CR44","doi-asserted-by":"publisher","first-page":"1214766","DOI":"10.3389\/fpubh.2023.1214766","volume":"11","author":"R Raycheva","year":"2023","unstructured":"Raycheva R, Kostadinov K, Mitova E, et al. Challenges in mapping European rare disease databases, relevant for ML-based screening technologies in terms of organizational, FAIR and legal principles: scoping review. Front Public Health. 2023;11:1214766. https:\/\/doi.org\/10.3389\/fpubh.2023.1214766.","journal-title":"Front Public Health"},{"key":"1019_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12961-025-01389-7","volume":"23","author":"MC S\u00e1nchez-Gonz\u00e1lez","year":"2025","unstructured":"S\u00e1nchez-Gonz\u00e1lez MC, Sarmiento-Su\u00e1rez R, Cellai LL, et al. Integrative research and innovation strategy for rare diseases. Insights from the 5-year European joint programme on rare diseases, including analysis to inform recommendations for future actions. Health Res Policy Syst. 2025;23:137. https:\/\/doi.org\/10.1186\/s12961-025-01389-7.","journal-title":"Health Res Policy Syst"},{"key":"1019_CR46","doi-asserted-by":"publisher","first-page":"100783","DOI":"10.1016\/j.lanepe.2023.100783","volume":"37","author":"B Tumien\u0117","year":"2023","unstructured":"Tumien\u0117 B, Juozapavi\u010di\u016bt\u0117 A, Andriukaitis V. Rare diseases: still on the fringes of universal health coverage in Europe. Lancet Reg Health Eur. 2023;37:100783.","journal-title":"Lancet Reg Health Eur"},{"key":"1019_CR47","unstructured":"Kroezen M, Buchan J, Dussault G et al. How can structured cooperation between countries address health workforce challenges related to highly specialized health care? Improving access to services through voluntary cooperation in the EU. In: Richardson E, Wismar M, editors. Copenhagen: European Observatory on Health Systems and Policies; 2016. Policy Brief No. 20. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK464518\/. Accessed 6 Jun 2026."},{"issue":"4","key":"1019_CR48","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3390\/healthcare12040458","volume":"12","author":"K Kostadinov","year":"2024","unstructured":"Kostadinov K, Marinova Y, Dimitrov K, et al. Navigating gene therapy access: the case of Bulgaria in the context of the EU regulatory landscape. Healthcare. 2024;12(4):458. https:\/\/doi.org\/10.3390\/healthcare12040458.","journal-title":"Healthcare"},{"issue":"11","key":"1019_CR49","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/children12111538","volume":"12","author":"E Hristova-Atanasova","year":"2025","unstructured":"Hristova-Atanasova E, Micallef M, Stivala J, et al. Preconception care and genetic screening: a global review and strategic perspectives for implementation in Bulgaria. Children. 2025;12(11):1538. https:\/\/doi.org\/10.3390\/children12111538.","journal-title":"Children"},{"issue":"6","key":"1019_CR50","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/14737167.2017.1388741","volume":"17","author":"AV Pejcic","year":"2017","unstructured":"Pejcic AV, Iskrov G, Raycheva R, et al. Transposition and implementation of EU rare disease policy in Eastern Europe. Expert Rev Pharmacoecon Outcomes Res. 2017;17(6):557\u201366. https:\/\/doi.org\/10.1080\/14737167.2017.1388741.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"1019_CR51","unstructured":"Berthereau J. Screening newborns could help fight rare diseases. Horizon: The EU Research & Innovation Magazine. 2024 Jun 26. https:\/\/projects.research-and-innovation.ec.europa.eu\/en\/horizon-magazine\/screening-newborns-help-fight-rare-diseases. Accessed 16 Jun 2025."},{"issue":"3","key":"1019_CR52","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/heapro\/daq080","volume":"26","author":"A R\u00fctten","year":"2011","unstructured":"R\u00fctten A, Gelius P, Abu-Omar K. Policy development and implementation in health promotion\u2014from theory to practice: the ADEPT model. Health Promot Int September. 2011;26(3):322\u20139. https:\/\/doi.org\/10.1093\/heapro\/daq080","journal-title":"Health Promot Int September"}],"container-title":["Therapeutic Innovation & Regulatory Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01019-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43441-026-01019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:07:09Z","timestamp":1793369229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43441-026-01019-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1019"],"URL":"https:\/\/doi.org\/10.1007\/s43441-026-01019-6","relation":{},"ISSN":["2168-4790","2168-4804"],"issn-type":[{"value":"2168-4790","type":"print"},{"value":"2168-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}